Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IN VIVO THROMBOSIS

Financiado

Cerrado

Interaction between major pathways for platelet activation in mouse models of ar...

Interaction between major pathways for platelet activation in mouse models of arterial thrombosis Platelets play a central role in arterial thrombosis, causing life-threatening and disabling diseases like myocardial infarction and ischemic stroke. Despite antiplatelet therapies have been proven efficacious for primary and seco... ver más

30/04/2011

UCSC

156K€

Presupuesto del proyecto: 156K€

Líder del proyecto

UNIVERSITA CATTOLICA DEL SACRO CUORE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2011-04-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UCSC

0.00€ | Lider

Proyectos interesantes

PLATELET RECEPTORS

Medical Technol...

Applied Physics

100K€ Cerrado

PDC2022-133743-I00

Medical Technol...

Pharmaceutical...

132K€ Cerrado

MEDICAMENTO GENÉRICO ANTICOAGULANTE ORAL DIRE...

Medical Technol...

Pharmaceutical...

467K€ Cerrado

JCI-2011-10417

Medical Technol...

Biomedical Imag...

96K€ Cerrado

ANTCARD

Medical Technol...

Pharmaceutical...

222K€ Cerrado

APAC-ON

Medical Technol...

Pharmaceutical...

3M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITA CATTOLICA DEL SACRO CUORE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 156K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Platelets play a central role in arterial thrombosis, causing life-threatening and disabling diseases like myocardial infarction and ischemic stroke. Despite antiplatelet therapies have been proven efficacious for primary and secondary prevention of cardio- and cerebrovascular diseases, arterial thrombosis remains a major healthy problem. A better understanding of the multiple mechanisms by which platelets can be activated is the basis for the rationale development of new antithrombotic drugs. The outgoing host institution involved in this project has previously demonstrated that protease-activated receptor (PAR) signaling in platelets is necessary for platelet activation by thrombin and important for hemostasis and thrombosis in mouse models. These results have greatly contributed to the development of a PAR1 antagonist, that has been recently used as antithrombotic drug in a phase II trial . The objectives of this proposal are to better define the role of thrombin signaling in vivo and to explore how the thrombin-PARs pathway relates to other effectors of hemostasis and thrombosis. This study will make use of mouse models of hemostasis and thrombosis. In the partner institution the generation of knockout mice for multiple platelet receptors (glycoprotein VI, FcγR, P2Y12 ) and other relevant molecules for hemostasis and thrombosis (vonWillebrand factor, FIX, FXI, fibrinogen) is ongoing. On those mice the following endpoints will be evaluated 1) hemostasis (bleeding time, neonatal hemorrhage, placentation, maternal hemorrhage, anemia) 2) thrombosis (by using a ferric chloride injury to induce carotid or mesenteric thrombosis). This project will allow the researcher to gain knowledge and experience on the in vivo models of hemostasis and thrombosis. This will be relevant for the fellowship program since the in vivo models will be set up during the return phase in the host institution.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores